Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario W Kramer

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
World Journal of Urology|April 3, 2014
Is there an anti-androgen withdrawal syndrome for enzalutamide?Christoph A J von Klot, Mario W Kramer, Alena Böker, et al.
Nature Communications|May 27, 2024
Proteomic analysis of the urothelial cancer landscapeFranz F Dressler, Falk Diedrichs, Deema Sabtan, et al.
Urology|December 3, 2024
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to CytologyThorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
Urologic Oncology|July 5, 2023
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter studyThorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
World Journal of Urology|February 14, 2024
Experts' recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-GroupGernot Ortner, Selcuk Güven, Bhaskar Kumar Somani, et al.
BJU International|December 20, 2021
Nomograms including the UBC<sup>®</sup> Rapid test to detect primary bladder cancer based on a multicentre datasetChristina J Meisl, Pierre I Karakiewicz, Roland Einarsson, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
World Journal of Urology|April 3, 2014
Is there an anti-androgen withdrawal syndrome for enzalutamide?Christoph A J von Klot, Mario W Kramer, Alena Böker, et al.
Nature Communications|May 27, 2024
Proteomic analysis of the urothelial cancer landscapeFranz F Dressler, Falk Diedrichs, Deema Sabtan, et al.
Urology|December 3, 2024
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to CytologyThorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
Urologic Oncology|July 5, 2023
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter studyThorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
World Journal of Urology|February 14, 2024
Experts' recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-GroupGernot Ortner, Selcuk Güven, Bhaskar Kumar Somani, et al.
BJU International|December 20, 2021
Nomograms including the UBC<sup>®</sup> Rapid test to detect primary bladder cancer based on a multicentre datasetChristina J Meisl, Pierre I Karakiewicz, Roland Einarsson, et al.
Pageof 8